Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol

(2012) Manuel A Gómez-Marcos et al.   BMC PUBLIC HEALTH

Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin

(2010) Marwa Mahmoud et al.   CIRCULATION RESEARCH

Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT)

(2010) Luisa Ojeda-Fernandez et al.   CLINICA CHIMICA ACTA

Soluble endoglin modulates aberrant cerebral vascular remodeling

(2009) Yongmei Chen et al.   ANNALS OF NEUROLOGY

Inhibition of VEGF or TGF-β Signaling Activates Endothelium and Increases Leukocyte Rolling

(2009) Tony E. Walshe et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease

(2009) D. Versari et al.   DIABETES CARE

Hereditary haemorrhagic telangiectasia: a clinical and scientific review

(2009) Fatima S Govani et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets

(2008) Maria Potenza et al.   CURRENT MEDICINAL CHEMISTRY

Hypertension Produced by Placental Ischemia in Pregnant Rats Is Associated With Increased Soluble Endoglin Expression

(2008) Jeffrey S. Gilbert et al.   HYPERTENSION

Hereditary haemorrhagic telangiectasia: a cause of preventable morbidity and mortality

(2008) A. P. Brady et al.   IRISH JOURNAL OF MEDICAL SCIENCE

Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction

(2008) Ignacio Cruz-Gonzalez et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE